News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,595 Results
Type
Article (2400)
Company Profile (45)
Press Release (35150)
Section
Business (14100)
Career Advice (76)
Deals (2073)
Drug Delivery (8)
Drug Development (4082)
Employer Resources (10)
FDA (427)
Job Trends (759)
News (20097)
Policy (1050)
Tag
Academia (143)
Alliances (3459)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (13)
Approvals (429)
Bankruptcy (11)
Best Places to Work (472)
Biosimilars (9)
Biotechnology (34)
Breast cancer (14)
Cancer (98)
Career advice (64)
CAR-T (9)
Cell therapy (30)
Clinical research (3118)
Collaboration (68)
Compensation (30)
COVID-19 (179)
C-suite (20)
Data (70)
Diagnostics (459)
Drug discovery (8)
Earnings (4142)
Events (5895)
Executive appointments (65)
FDA (462)
Funding (61)
Gene editing (10)
Gene therapy (9)
GLP-1 (58)
Government (146)
Healthcare (700)
Infectious disease (182)
Inflammatory bowel disease (10)
Intellectual property (8)
IPO (979)
Job creations (289)
Job search strategy (62)
Layoffs (35)
Legal (210)
Lung cancer (15)
Manufacturing (16)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1138)
Metabolic disorders (24)
Neuroscience (77)
NextGen: Class of 2025 (352)
Non-profit (154)
Northern California (263)
Obesity (11)
Opinion (13)
Patents (12)
People (5573)
Phase I (1342)
Phase II (1570)
Phase III (831)
Pipeline (41)
Postmarket research (30)
Preclinical (581)
Radiopharmaceuticals (12)
Rare diseases (13)
Real estate (419)
Regulatory (785)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (16)
Southern California (255)
Startups (487)
United States (1255)
Vaccines (22)
Weight loss (8)
Date
Today (13)
Last 7 days (32)
Last 30 days (158)
Last 365 days (2584)
2025 (148)
2024 (2616)
2023 (2858)
2022 (3751)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (42)
Arizona (13)
Asia (1843)
Australia (294)
California (598)
Canada (110)
China (31)
Colorado (13)
Connecticut (9)
Europe (3776)
Florida (35)
Illinois (13)
Indiana (23)
Kansas (12)
Maryland (21)
Massachusetts (210)
Minnesota (14)
New Jersey (37)
New York (36)
North Carolina (78)
Northern California (263)
Ohio (21)
Pennsylvania (27)
South America (40)
Southern California (255)
Texas (49)
Washington State (33)
37,595 Results for "nexcelom bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Deals
Ampersand Completes Sale of Portfolio Company Nexcelom Bioscience to PerkinElmer
Ampersand Capital Partners announced that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash.
June 25, 2021
·
2 min read
Deals
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience
PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash.
May 12, 2021
·
6 min read
Press Releases
Anixa Biosciences CEO Provides Letter to Shareholders
January 21, 2025
·
6 min read
Press Releases
Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ
January 22, 2025
·
2 min read
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
Press Releases
Michael Scholle Appointed CEO of Tango Biosciences
January 7, 2025
·
2 min read
Press Releases
Junshi Biosciences Announces Toripalimab’s Approval in Australia
January 17, 2025
·
9 min read
Press Releases
Targeted Bioscience Unveils Revolutionary Extracellular Vesicle Isolation Kit
January 22, 2025
·
2 min read
Press Releases
Genflow Biosciences PLC Announces 2024 Highlights
January 6, 2025
·
7 min read
1 of 3,760
Next
